These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2070335

  • 21. Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis.
    Kostopoulos IV, Paterakis G, Papadimitriou K, Pavlidis D, Tsitsilonis OE, Papadhimitriou SI.
    Genes Chromosomes Cancer; 2015 Apr; 54(4):210-21. PubMed ID: 25533355
    [Abstract] [Full Text] [Related]

  • 22. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP, Variakojis D, Peterson LC.
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [Abstract] [Full Text] [Related]

  • 23. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I, Majda JA, Baird SM, Meserve BL, Griffiths JC.
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [Abstract] [Full Text] [Related]

  • 24. [Chronic lymphatic leukemia from B CD5+ cells: characteristics, clinical and laboratory features, and immunophenotyping].
    Dwilewicz-Trojaczek J.
    Pol Tyg Lek; 1995 Oct; 50(40-44):12-4. PubMed ID: 8650049
    [Abstract] [Full Text] [Related]

  • 25. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y, Tong X, Huang L, Li L, Wang C, He C, Liu S, Wang Z, Xiao M, Mao X, Zhang D.
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [Abstract] [Full Text] [Related]

  • 26. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC.
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [Abstract] [Full Text] [Related]

  • 27. Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins.
    Molica S, Levato D, Dattilo A, Mannella A.
    Eur J Haematol; 1998 Jan; 60(1):47-52. PubMed ID: 9451427
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.
    Tefferi A, Bartholmai BJ, Witzig TE, Li CY, Hanson CA, Phyliky RL.
    Am J Clin Pathol; 1996 Oct; 106(4):457-61. PubMed ID: 8853032
    [Abstract] [Full Text] [Related]

  • 29. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC, Finn WG, Goolsby CL, Variakojis D, Peterson LC.
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [Abstract] [Full Text] [Related]

  • 30. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
    Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E.
    Blood; 1991 Oct 01; 78(7):1795-802. PubMed ID: 1717071
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
    Criado I, Muñoz-Criado S, Rodríguez-Caballero A, Nieto WG, Romero A, Fernández-Navarro P, Alcoceba M, Contreras T, González M, Orfao A, Almeida J, Primary Health Care Group of Salamanca for the Study of MBL.
    Haematologica; 2017 Jul 01; 102(7):1238-1246. PubMed ID: 28385786
    [Abstract] [Full Text] [Related]

  • 33. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
    Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D.
    Am J Clin Pathol; 1997 Oct 01; 108(4):378-82. PubMed ID: 9322589
    [Abstract] [Full Text] [Related]

  • 34. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Monaghan SA, Peterson LC, James C, Marszalek L, Khoong A, Bachta DJ, Karpus WJ, Goolsby CL.
    Cytometry B Clin Cytom; 2003 Nov 01; 56(1):30-42. PubMed ID: 14582135
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
    Faguet GB, Marti GE, Agee JF, Bertin P.
    Ann N Y Acad Sci; 1992 May 04; 651():470-3. PubMed ID: 1376063
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA, Fisher J, Craig FE.
    Cytometry B Clin Cytom; 2013 May 04; 84(3):149-56. PubMed ID: 23475845
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.